This study is a multi-site clinical trial of the safety and efficacy of transdermal nicotine in alleviating symptoms of MCI, designed to test the hypothesis that nicotinic cholinergic receptor stimulation reliably produces enhancement in attentional functioning and memory.
|Effective start/end date||6/1/16 → 1/31/22|
- University of Southern California (81622655//6R01AG047992-02)
- National Institute on Aging (81622655//6R01AG047992-02)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.